We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Intended Use Rule Still Ambiguous, Attorneys Say
FDA’s Intended Use Rule Still Ambiguous, Attorneys Say
The FDA’s long-awaited final rule on the agency’s current practices in evaluating whether a product is intended for use as a drug or device was supposed to provide clarity, but there are still unanswered questions, according to attorneys at Ropes & Gray.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor